Inhibition of human cytochromes P450 by components of Ginkgo biloba. - Wikidata - wikimedia - TriplyDB

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

http://www.wikidata.org/entity/Q34337497

about

CYP4F2 is a vitamin K1 oxidase: An explanation for altered warfarin dose in carriers of the V433M variant Pharmacokinetic interactions of herbs with cytochrome p450 and p-glycoprotein A survey of across-target bioactivity results of small molecules in PubChem Drug-botanical interactions: a review of the laboratory, animal, and human data for 8 common botanicals.Which sources of flavonoids: complex diets or dietary supplements?Effect of Ginkgo biloba special extract EGb 761® on human cytochrome P450 activity: a cocktail interaction study in healthy volunteers.Interaction of warfarin with drugs, natural substances, and foods.Plasma metabolomic profiles enhance precision medicine for volunteers of normal health.Modulation of Hepatic Cytochrome P450 Enzymes by Curcumin and its Pharmacokinetic Consequences in Sprague-dawley Rats The effective method for investigation meridian tropism theory in rats.Pharmacovigilance: effects of herbal components on human drugs interactions involving cytochrome P450 Updates on the clinical evidenced herb-warfarin interactions.Herb-drug interactions: focus on metabolic enzymes and transporters.Pharmacokinetic drug interactions involving Ginkgo biloba.Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.The Neuroprotective Effect of Syringic Acid on Spinal Cord Ischemia/Reperfusion Injury in Rats.Effects of myricetin on the bioavailability of carvedilol in rats.Effect of health foods on cytochrome P450-mediated drug metabolism.Effects of Schisandra sphenanthera extract on the pharmacokinetics of midazolam in healthy volunteers.Effects of notoginsenoside R1 on CYP1A2, CYP2C11, CYP2D1, and CYP3A1/2 activities in rats by cocktail probe drugs.In-vitro and in-vivo evaluations of cytochrome P450 1A2 interactions with nuciferine.Effects of herbal supplements on the bioactivation of chemotherapeutic agents.Demethylzeylasteral exhibits strong inhibition towards UDP-glucuronosyltransferase (UGT) 1A6 and 2B7.Influence of the Ginkgo extract EGb 761 on rat liver cytochrome P450 and steroid metabolism and excretion in rats and man.Metabolism of the anthelmintic drug niclosamide by cytochrome P450 enzymes and UDP-glucuronosyltransferases: metabolite elucidation and main contributions from CYP1A2 and UGT1A1.Ginkgo biloba does not alter clearance of flurbiprofen, a cytochrome P450-2C9 substrate.Evaluation of the effect of quercetin treatment on CYP2C9 enzyme activity of diclofenac in healthy human volunteers.Pomegranate juice does not impair clearance of oral or intravenous midazolam, a probe for cytochrome P450-3A activity: comparison with grapefruit juice.Effects of Ginkgo biloba extract on pharmacokinetics and pharmacodynamics of tolbutamide and midazolam in healthy volunteers.The in-vitro effect of complementary and alternative medicines on cytochrome P450 2C9 activity.Anti-cancer potential of flavonoids: recent trends and future perspectives.The Effect of Myricetin on Pharmacokinetics of Atomoxetine and its Metabolite 4-Hydroxyatomoxetine In Vivo and In Vitro.Modulation of Cytochrome P450 Activity by 18β-Glycyrrhetic Acid and its Consequence on Buspirone Pharmacokinetics in Rats.Effects ofGinkgo bilobaextracts on pharmacokinetics and efficacy of atorvastatin based on plasma indices In vitro antioxidant properties of the biflavonoid agathisflavone

P2860

Q24322624-F16708A1-70FB-4D60-9DA5-D3A792790104 Q28087178-52072398-5870-4CB5-9A1A-25A39459AD90 Q28751797-C735A151-1914-40F4-9974-7C084AAC4FBC Q33509452-FC15D071-C68E-4B82-AF31-B1A740F6E03F Q34591974-B80962F4-E944-488B-9BBA-84B3B4E0726A Q35904433-2173017E-1B00-4B17-8AAA-0A116373DBAE Q36007599-A1C283DD-A8BE-44A3-9E95-E66687DC5D59 Q36055457-A6E75E5B-7BA4-4162-9F56-5E9F6CD7794C Q36675712-8740D3CF-0F0B-4F35-891A-87890CADE445 Q37103041-CBF711CD-B131-4E6B-8DDD-6E2718F57A73 Q37405210-A9EF1492-63F2-4656-AF6E-DD2BBE97972A Q37686931-A44E2F16-9AC3-4200-8D28-B33A1EF63B32 Q37964576-07D002FA-42AC-4800-9D86-4DBE8488662B Q38122439-34FB546B-02F1-4C00-A9A8-97EFA56FE91C Q38283110-B3E7E708-BEDE-4E8B-AA59-3189B62BA755 Q39015027-941854BD-7951-476D-9DCB-D7F4EECE5A06 Q39434669-9883024F-8BDD-4274-B0E4-C20E3F2BFF8D Q40216004-971807F3-CDD6-4F8F-A3F2-8AFD5BF816B3 Q41827847-A48E5520-44EF-4F4F-A27F-DF9F5BF51068 Q42702118-0DE3F5F2-5E18-4FEF-9D7D-EFAD98FE6998 Q42978371-11C177A0-8059-4D3F-9098-974A2467CD1D Q43762616-0F4D4E6D-7C20-435B-865E-9EBF65170A68 Q46089447-2EA9AEC5-498F-44E7-BE6A-263787ADCF02 Q46496826-A09E2104-32D2-4D90-B1F2-0FCF97A0A93B Q46715656-41E4439C-F0F3-4A1E-BF00-F23C1689D616 Q46908034-79107B70-5D00-410D-A555-7E68AAB07072 Q48248312-190667EB-1C91-4E6E-A5BA-79F1E372A0AA Q48618446-2E46C213-DBD1-4127-88D1-5606B3F791BA Q48651682-706254C1-EC0A-44E3-8BE3-A6124CE845A8 Q50457694-5BC92F39-B6A3-4C90-BCED-9FBA64124ABC Q51527710-6222834B-ED87-4E9E-B143-8EFAEAC75BC1 Q52868157-432ECE17-DA93-4F00-A61B-54ADA3EC7D90 Q53492647-DC6D75DC-C55B-4F34-8736-E7807B827629 Q57500258-26424299-83C9-4ECC-BF00-F960EF496235 Q57929173-005A8D7A-C7A2-4C6F-9A80-C85B5F62060D

P2860

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

http://www.wikidata.org/entity/Q34337497

description

2004 nî lūn-bûn

@nan

2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@ast

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@en

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@nl

type

label

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@ast

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@en

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@nl

prefLabel

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@ast

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@en

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@nl

P1433

Q34337497-B2F3D92F-27C1-46E2-B281-FB3239277740

P1476

Q34337497-5D3A8119-EA91-4DE4-A182-1FC596492CD5

P2093

Q34337497-45FFF6D4-B51D-4675-8E12-19BAC3F2F745

Q34337497-6AE6F6DD-3A2E-4838-A272-45990F412ECC

Q34337497-B38D5E92-ABF5-4C09-B44B-745438810120

Q34337497-B70F0479-090A-4512-98D8-8802E3582044

Q34337497-BE25D709-9B6F-48C9-8244-62C2B05EC6CC

Q34337497-D9199E55-5947-4CD5-9D11-020F52F11B35

P2860

Q34337497-0C0379E1-87E7-4276-A9B3-44BD617D4699

Q34337497-0F3FF168-08EC-49BE-AC89-F9C96E6D210D

Q34337497-1CE4D17F-9E5E-4661-B917-0FAD59738F35

Q34337497-1E4C85C9-8653-4E38-9497-B85C91DF88CC

Q34337497-261CE3CC-2DE1-455D-BC3A-BF06EFCDB514

Q34337497-354D6534-1100-4018-BAC4-1C8644EB3084

Q34337497-3B1A57FC-9F91-41EA-8F71-40E4BF966291

Q34337497-56EEE5D8-CB19-49C8-A4B9-251B15BDB6AD

Q34337497-576E7722-2414-4F61-9521-3953EE7F6B70

Q34337497-59928FD2-4ADD-4254-BDBC-EEB24186ED11

P304

Q34337497-8795BA33-E80A-42E7-AE43-4E9C48585D24

P31

Q34337497-A8FB1370-A018-4114-9223-197E33013856

P356

Q34337497-3D2ABF98-5D62-4799-9B68-2E7DC8D80622

P433

Q34337497-3F93D102-2FCC-40CE-A336-0B21E4C428A1

P478

Q34337497-D362402B-70B1-4777-993C-C19E5637D289

P50

Q34337497-7B3E404E-B863-49FC-B683-0189ED010057

P577

Q34337497-5327CCAD-000A-4BF8-990C-2C951D58AD8D

P698

Q34337497-65737B68-9692-4394-814E-F04FF0FE8223

P921

Q34337497-D1921CFD-08F2-4344-A7D1-6F430CCCE4A0

P356

P1433

Journal of Pharmacy and Pharmacology

P1476

Inhibition of human cytochromes P450 by components of Ginkgo biloba.

@en

P2093

David J Greenblatt

http://www.w3.org/2001/XMLSchema#string

Ikhlas A Khan

http://www.w3.org/2001/XMLSchema#string

James L Weemhoff

http://www.w3.org/2001/XMLSchema#string

Jerold S Harmatz

http://www.w3.org/2001/XMLSchema#string

Lisa L von Moltke

http://www.w3.org/2001/XMLSchema#string

Peter Goldman

http://www.w3.org/2001/XMLSchema#string

P2860

Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey

Interactions between herbal medicines and prescribed drugs: a systematic review.

Herb-drug interactions.

Herbal medicines today and the roots of modern pharmacology.

Chemical analysis of Ginkgo biloba leaves and extracts.

Multiple-dose administration of Ginkgo biloba did not affect cytochrome P-450 2D6 or 3A4 activity in normal volunteers.

Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.

The risk-benefit profile of commonly used herbal therapies: Ginkgo, St. John's Wort, Ginseng, Echinacea, Saw Palmetto, and Kava.

Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects.

The CNS effects of Ginkgo biloba extracts and ginkgolide B.

P304

1039-1044

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1211/0022357044021

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

P577

2004-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15285849

http://www.w3.org/2001/XMLSchema#string

P921